[
    "{\"step_by_step_thinking\": \"The patient is a 55-year-old woman with a history of invasive ductal adenocarcinoma that is estrogen receptor positive. She is currently taking tamoxifen, which is a selective estrogen receptor modulator (SERM) commonly used in the treatment of breast cancer. Tamoxifen has been associated with an increased risk of deep venous thrombosis (DVT) and pulmonary embolism. Therefore, option A, deep venous thrombosis, is a potential complication that could occur in this patient.\", \"answer_choice\": \"A\"}"
]